The relationship of transforming growth factor-β1 gene polymorphism, its plasma level, and gingival overgrowth in renal transplant recipients receiving different immunosuppressive regimens

Journal of Periodontology

Volumn 77, Issue 5, 2006, Pages 865-873

  Radwan Oczko, Małgorzata ^a   Boratyńska, Maria ^a   Zietek, Marek ^a   Zołedziewska, Magdalena ^a   Jonkisz, Anna ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cyclosporin A; Gene; Gingival overgrowth; Polymorphism; Renal transplant; Transforming growth factor beta 1

Indexed keywords

AMLODIPINE; AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NITRENDIPINE; PREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA1; TSUKUBAENOLIDE; VERAPAMIL; CYCLOSPORIN; TACROLIMUS; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGE; ARTICLE; BLEEDING; CODON; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DRUG DOSE REGIMEN; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GINGIVA OVERGROWTH; HETEROZYGOSITY; HUMAN; INCIDENCE; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; RISK FACTOR; SEX; VOLUNTEER; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; METABOLISM; NONPARAMETRIC TEST;

ADULT; CODON; CYCLOSPORINE; FEMALE; GENOTYPE; GINGIVAL OVERGROWTH; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; POLYMORPHISM, GENETIC; STATISTICS, NONPARAMETRIC; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33746021142     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.050086     Document Type: Article

References (37)

1. Spratt H, Boomer S, Irwin CR, et al. Cyclosporin associated gingival overgrowth in renal transplant recipients. Oral Dis 1999;5:27-31.
2. Thomason JM, Kelly PJ, Seymour RA. The distribution of gingival overgrowth in organ transplant patients. J Clin Periodontol 1996;23:367-371.
3. Daly CG. Resolution of cyclosporin A (CsA)-induced gingival enlargement following reduction in CsA dosage. J Clin Periodontol 1992;19:143-145.
4. Pernu HE, Pernu LM, Knuuttila ML. Effect of periodontal treatment on gingival overgrowth among cyclosporine A treated renal transplant recipients. J Periodontol 1993;64:1098-1100.
5. Varga E, Lennon MA, Mair LH. Pre-transplant gingival hyperplasia predicts severe cyclosporin-induced gingival overgrowth in renal transplant patients. J Clin Periodontol 1998;25:225-230.
6. Thomason JM, Seymour RA, Ellis JS, et al. Iatrogenic gingival overgrowth in cardiac transplantation. J Periodontol 1995;66:742-746.
7. David-Neto E, Lemos FBC, Furusawa EA, et al. Impact of cyclosporin A pharmacokinetics on the presence of side effects in pediatric renal transplantation. J Am Soc Nephrol 2000;11:343-349.
8. Thomason JM, Seymour RA, Ellis JS. Determinants of gingival overgrowth severity in organ transplant patients. An examination of the role of HLA phenotype. J Clin Periodontol 1996;23:628-634.
9. Radwan-Oczko M, Boratyńska M, Klinger M, Zietek M. Risk factors of gingival overgrowth in kidney transplant recipients treated with cyclosporine A. Ann Transplant 2003;8:57-62.
10. Boratyńska M, Radwan-Oczko M, Falkiewicz K, Klinger M, Szyber P. Gingival overgrowth in kidney transplant recipients treated with cyclosporine and its relationship with chronic graft nephropathy. Transplant Proc 2003;35:2238-2240.
11. Mariani G, Calastrini C, Aleotti A. Ultrastructural changes in Langerhans cells in gingival overgrowth in cyclosporine A-treated transplant patients. Pathology 2004;36:242-246.
12. Afonso M, Oliveira Bello V, Shibli JA, Sposto MR. Cyclosporin A-induced gingival overgrowth in renal transplant recipients. J Periodontol 2003;74:51-56.
13. Bartoli F, Castronovo G, Stabile A. Risk factors conditioning the incidence and severity of cyclosporine A-induced gingival overgrowth and methods of prevention. Minerva Stomatol 2004;53:165-170.
14. Yamaguchi M, Naruishi K, Yamada-Naruishi H, Omori K, Nishimura F, Takashiba S. Long-term cyclosporine A exposure suppresses cathepsin-B and -L activity in gingival fibroblasts. J Periodontal Res 2004;39: 320-326.
15. Paik JW, Kim CS, Cho KS, Chai JK, Kim CK, Choi SH. Inhibition of cyclosporin A-induced gingival overgrowth by azithromycin through phagocytosis: An in vivo and in vitro study. J Periodontol 2004;75: 380-387.
16. Mathur H, Moretti AJ, Flaitz CM. Regression of cyclosporin-induced gingival overgrowth upon interruption of drug therapy. Gen Dent 2003;51:159-162.
17. Margiotta V, Pizzo I, Pizzo G, Barbaro A. Cyclosporin- and nifedipine-induced gingival overgrowth in renal transplant patients: Correlations with periodontal and pharmacological parameters, and HLA-antigens. J Oral Pathol Med 1996;25:128-134.
18. Berloco P, Rossi M, Pretagostini R, Sociu-Foca Cortesini N, Coitesini R. Tacrolimus as cornerstone immunosuppressant in kidney transplantation. Transplant Proc 2001;33:994-996.
19. Thorp M, DeMattos A, Bennett W, Barry J, Norman D. The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol. Transplantation 2000;69:1218-1224.
20. Kohnle M, Lütkes P, Zimmermann U, Philipp T, Heemann U. Conversion from cyclosporine to tacrolimus in renal transplant recipients with gum hyperplasia. Transplant Proc 1999;31:44S-45S.
21. Busque S, Demers P, St-Louis G, et al. Conversion from Neoral (cyclosporine) to tacrolimus of kidney transplant recipients for gingival hyperplasia or hypertrichosis. Transplant Proc 1998;30:1247-1248.
22. Hernandez G, Arriba L, Cruz Frias M, et al. Conversion from cyclosporin A to tacrolimus as non-surgical alternative to reduce gingival enlargement: A preliminary case series. J Periodontol 2003;74:1816-1823.
23. Wright HJ, Chapple IL, Matthews JB. TGF-beta isoforms and TGF-beta receptors in drug-induced and hereditary gingival overgrowth. J Oral Pathol Med 2001;30:281-289.
24. Li Y, Foster W, Deasy BM, et al. Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: A key event in muscle fibrogenesis. Am J Pathol 2004; 164:1007-1019.
25. Yamada Y, Miyauchi A, Goto J, et al. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 1998;13:1569-1576.
26. Hoffmann SC, Stanley EM, Cox ED. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation 2001;72: 1444-1450.
27. Linden GJ, Haworth SE, Maxwell AP. The influence of transforming growth factor-beta1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporin A and a calcium channel blocker. J Periodontol 2001;72: 808-814.
28. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-beta1 gene: Association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998;66:1014-1020.
29. Mühlemann HR, Son S. Gingival sulcus bleeding - A leading symptom in initial gingivitis. Helv Odont Acta 1971;15:107-111.
30. Coletta RD, Almeida OP, Reynolds MA, Sauk JJ. Alteration in expression of MMP-1 and MMP-2 but not TIMP-1 and TIMP-2 in hereditary gingival fibromatosis is mediated by TGF-β1 autocrine stimulation. J Periodontal Res 1999;34:457-463.
31. Martelli-Junior H, Cotrim P, Graner E, Sauk JJ, Coletta RD. Effect of transforming growth factor-beta1, interleukin-6, and interferon-gamma on the expression of type I collagen, heat shock protein 47, matrix metalloproteinase (MMP)-1 and MMP-2 by fibroblasts from normal gingiva and hereditary gingival fibromatosis. J Periodontol 2003;74:296-306.
32. Gnoatto N, Lotufo RF, Toffoletto O, Marquezini MV. Gene expression of extracellular matrix proteoglycans in human cyclosporin-induced gingival overgrowth. J Periodontol 2003;74:1747-1753.
33. James JA, Irwin CR, Linden GJ. Gingival fibroblast response to cyclosporin A and transforming growth factor beta 1. J Periodontol Res 1998;33:40-48.
34. Wright HJ, Chapple IL, Blair F, Matthews JB. Crevicular fluid levels of TGF-beta1 in drug-induced gingival overgrowth. Arch Oral Biol 2004;49:421-425.
35. Steinsvoll S, Halstensen TS, Schenck K. Extensive expression of TGF-beta1 in chronically-inflamed periodontal tissue. J Clin Periodontol 1999;26: 366-373.
36. Baan CC, Balk AH, Holweg CT, et al. Renal failure after clinical heart transplantation is associated with the TGF-beta 1 codon 10 gene polymorphism. J Heart Lung Transplant 2000;19:866-872.
37. Ochsner S, Guo Z, Binswanger U, Knoflach A. TGF-beta1 gene expression in stable renal transplant recipients: Influence of TGF-beta1 gene polymorphism and immunosuppression. Transplant Proc 2002;34:2901-2903.